2022 Q4 Form 10-K Financial Statement

#000149315222036671 Filed on December 28, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2022
Revenue $11.97M $13.24M $50.27M
YoY Change 12.16% -9.96% 16.56%
Cost Of Revenue $6.928M $7.986M $31.22M
YoY Change 1.83% -18.52% 19.33%
Gross Profit $5.043M $5.257M $19.06M
YoY Change 30.33% 7.16% 12.3%
Gross Profit Margin 42.13% 39.7% 37.9%
Selling, General & Admin $5.456M $7.438M $27.76M
YoY Change -17.49% 19.94% 23.15%
% of Gross Profit 108.19% 141.48% 145.66%
Research & Development $1.538M $1.377M $4.852M
YoY Change 17.27% 21.01% 52.97%
% of Gross Profit 30.5% 26.19% 25.46%
Depreciation & Amortization $530.8K $516.3K $1.863M
YoY Change 101.97% 42.23% 39.51%
% of Gross Profit 10.53% 9.82% 9.78%
Operating Expenses $6.994M $8.815M $35.92M
YoY Change -11.73% 20.11% 39.73%
Operating Profit -$1.951M -$3.558M -$16.87M
YoY Change -51.87% 46.23% 92.96%
Interest Expense $1.128M -$243.7K $3.898M
YoY Change -180.27% -76.35% -233.42%
% of Operating Profit
Other Income/Expense, Net -$1.145M $3.928M $3.368M
YoY Change -223.13% 76.49% -72.91%
Pretax Income -$3.097M -$3.189M -$13.50M
YoY Change -31.64% 157.69% -1855.15%
Income Tax $39.40K -$208.5K
% Of Pretax Income
Net Earnings -$6.277M -$3.141M -$13.02M
YoY Change 40.18% -67.51% 66.76%
Net Earnings / Revenue -52.44% -23.72% -25.9%
Basic Earnings Per Share
Diluted Earnings Per Share -$8.24 -$119.1K -$524.4K
COMMON SHARES
Basic Shares Outstanding 27.78M shares 26.41M shares 24.83M shares
Diluted Shares Outstanding 761.6K shares 24.83M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.782M $10.62M $10.62M
YoY Change -44.15% -31.2% -31.2%
Cash & Equivalents $5.769M $10.61M $10.61M
Short-Term Investments $13.72K $13.72K $13.72K
Other Short-Term Assets $1.126M $1.341M $4.153M
YoY Change -74.19% 17.72% -4.42%
Inventory $8.605M $9.532M $9.532M
Prepaid Expenses $536.8K
Receivables $6.936M $5.961M $5.961M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $26.40M $30.27M $30.27M
YoY Change -8.46% -12.87% -12.87%
LONG-TERM ASSETS
Property, Plant & Equipment $5.108M $6.106M $8.747M
YoY Change -46.02% -9.39% -9.62%
Goodwill $3.907M $4.505M
YoY Change -42.4%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.546M $1.474M $1.474M
YoY Change 121.63% 111.4% 111.4%
Total Long-Term Assets $14.51M $15.49M $15.49M
YoY Change -19.31% -14.89% -14.89%
TOTAL ASSETS
Total Short-Term Assets $26.40M $30.27M $30.27M
Total Long-Term Assets $14.51M $15.49M $15.49M
Total Assets $40.91M $45.76M $45.76M
YoY Change -12.63% -13.57% -13.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.723M $3.257M $3.276M
YoY Change -22.47% -23.1% -22.65%
Accrued Expenses $3.246M $2.281M $3.100M
YoY Change 43.12% 40.73% 5.98%
Deferred Revenue $2.506M $1.951M
YoY Change -2.64%
Short-Term Debt $17.10M $16.89M $0.00
YoY Change 69.32%
Long-Term Debt Due $17.10M $16.89M $16.89M
YoY Change 125.23% 69.32% 69.32%
Total Short-Term Liabilities $26.87M $25.51M $25.51M
YoY Change 67.53% 29.82% 29.82%
LONG-TERM LIABILITIES
Long-Term Debt $3.196M $2.368M $2.368M
YoY Change -38.3% -63.05% -63.05%
Other Long-Term Liabilities $582.4K $807.9K $3.238M
YoY Change -81.71% -3.73% -2.61%
Total Long-Term Liabilities $5.242M $5.605M $5.605M
YoY Change -37.33% -42.4% -42.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.87M $25.51M $25.51M
Total Long-Term Liabilities $5.242M $5.605M $5.605M
Total Liabilities $32.11M $31.12M $31.81M
YoY Change 26.85% 5.9% 4.82%
SHAREHOLDERS EQUITY
Retained Earnings -$61.21M -$54.93M
YoY Change 31.07%
Common Stock $794.00 $26.41K
YoY Change 27.1%
Preferred Stock
YoY Change
Treasury Stock (at cost) $148.3K $148.3K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $8.163M $13.94M $13.94M
YoY Change
Total Liabilities & Shareholders Equity $40.91M $45.76M $45.76M
YoY Change -12.63% -13.57% -13.57%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2022
OPERATING ACTIVITIES
Net Income -$6.277M -$3.141M -$13.02M
YoY Change 40.18% -67.51% 66.76%
Depreciation, Depletion And Amortization $530.8K $516.3K $1.863M
YoY Change 101.97% 42.23% 39.51%
Cash From Operating Activities -$3.371M -$5.847M -$16.09M
YoY Change -22.56% 50.98% 60.12%
INVESTING ACTIVITIES
Capital Expenditures $571.7K -$841.5K $1.845M
YoY Change -289.71% -1996.12% -272.51%
Acquisitions
YoY Change
Other Investing Activities $210.9K $6.935M $8.455M
YoY Change 2083.02% 979.82% 342.62%
Cash From Investing Activities -$360.8K $6.093M $6.610M
YoY Change 23.7% 787.47% 686.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$600.9K -879.8K $5.023M
YoY Change -5.03% -119.02% 12.97%
NET CHANGE
Cash From Operating Activities -$3.371M -5.847M -$16.09M
Cash From Investing Activities -$360.8K 6.093M $6.610M
Cash From Financing Activities -$600.9K -879.8K $5.023M
Net Change In Cash -$4.333M -633.4K -$4.461M
YoY Change -17.9% -143.98% -6.37%
FREE CASH FLOW
Cash From Operating Activities -$3.371M -$5.847M -$16.09M
Capital Expenditures $571.7K -$841.5K $1.845M
Free Cash Flow -$3.943M -$5.005M -$17.94M
YoY Change -2.69% 27.78% 99.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
usd
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
usd
CY2021 CETX Provision For Doubtful Accounts Related Party
ProvisionForDoubtfulAccountsRelatedParty
usd
CY2021 CETX Accounts Payable Paid In Equity Shares
AccountsPayablePaidInEquityShares
usd
CY2022 CETX Settlement Agreement Related Party
SettlementAgreementRelatedParty
usd
CY2021Q3 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
usd
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2022Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2021 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
usd
CY2021 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest
usd
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
usd
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001435064
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q3 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
usd
CY2021Q3 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
usd
CY2021Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
usd
CY2022Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
usd
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
usd
CY2022 CETX Settlement Agreement Related Party
SettlementAgreementRelatedParty
usd
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
usd
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2022 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
usd
CY2022 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest
usd
CY2022Q3 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
usd
CY2022 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
usd
CY2021 CETX Increase Decrease In Accounts Payable Related Party
IncreaseDecreaseInAccountsPayableRelatedParty
usd
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
CY2022 CETX Payments For Investment In Virtual Driver Interactive
PaymentsForInvestmentInVirtualDriverInteractive
usd
CY2022 CETX Payments On Capital Lease Liabilities
PaymentsOnCapitalLeaseLiabilities
usd
CY2022 CETX Proceeds From Paycheck Protection Program Loans
ProceedsFromPaycheckProtectionProgramLoans
usd
CY2022 CETX Investment In Virtual Driver Interactive
InvestmentInVirtualDriverInteractive
usd
CY2021 CETX Stock Issued To Pay For Services
StockIssuedToPayForServices
usd
CY2021 CETX Shares Issued In Connection With Note Payable
SharesIssuedInConnectionWithNotePayable
usd
CY2021 CETX Investment In Right Of Use Asset
InvestmentInRightOfUseAsset
usd
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
usd
CY2022Q3 CETX Finance Lease Liabilities Current
FinanceLeaseLiabilitiesCurrent
usd
CY2021Q3 CETX Finance Lease Liabilities Current
FinanceLeaseLiabilitiesCurrent
usd
CY2022Q3 CETX Finance Lease Liabilities Noncurrent
FinanceLeaseLiabilitiesNoncurrent
usd
CY2021Q3 CETX Finance Lease Liabilities Noncurrent
FinanceLeaseLiabilitiesNoncurrent
usd
CY2022 CETX Depreciation Of Finance Lease Assets
DepreciationOfFinanceLeaseAssets
usd
CY2022 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
usd
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
usd
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
usd
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
usd
CY2021Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-37464
CY2022 dei Entity Registrant Name
EntityRegistrantName
CEMTREX, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
30-0399914
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
276 Greenpoint Ave
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 208
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Brooklyn
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
11222
CY2022 dei City Area Code
CityAreaCode
631
CY2022 dei Local Phone Number
LocalPhoneNumber
756-9116
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Public Float
EntityPublicFloat
15494633 usd
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27778856 shares
CY2022 dei Auditor Name
AuditorName
Grassi & Co, CPAs, P.C.
CY2022 dei Auditor Location
AuditorLocation
Jericho, New York
CY2022 dei Auditor Firm
AuditorFirmId
606
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10610181 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15426976 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1577915 usd
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1759347 usd
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
13721 usd
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
14981 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5960686 usd
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7810896 usd
CY2021Q3 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
1487155 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
9531682 usd
CY2021Q3 us-gaap Inventory Net
InventoryNet
5657287 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2575105 usd
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2585652 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
30269290 usd
CY2021Q3 us-gaap Assets Current
AssetsCurrent
34742294 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6106292 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6738944 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2641198 usd
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2940127 usd
CY2022Q3 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
761585 usd
CY2022Q3 us-gaap Goodwill
Goodwill
4505283 usd
CY2021Q3 us-gaap Goodwill
Goodwill
7821283 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1473980 usd
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
697240 usd
CY2022Q3 us-gaap Assets
Assets
45757628 usd
CY2021Q3 us-gaap Assets
Assets
52939888 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3256559 usd
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4235002 usd
CY2022Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
19133 usd
CY2022Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
16894743 usd
CY2021Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
9977972 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
818730 usd
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
830791 usd
CY2022Q3 us-gaap Deposits
Deposits
198178 usd
CY2021Q3 us-gaap Deposits
Deposits
536220 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2281324 usd
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1621053 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1951282 usd
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2004170 usd
CY2022Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
94848 usd
CY2021Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
448194 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
25514797 usd
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
19653402 usd
CY2022Q3 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
110331 usd
CY2021Q3 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
767279 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1822468 usd
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2017408 usd
CY2021Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
2350000 usd
CY2022Q3 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
2160169 usd
CY2021Q3 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
2257785 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
807898 usd
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
839171 usd
CY2022Q3 CETX Paycheck Protection Program Loans
PaycheckProtectionProgramLoans
97120 usd
CY2021Q3 CETX Paycheck Protection Program Loans
PaycheckProtectionProgramLoans
1032200 usd
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
607309 usd
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
467967 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5605295 usd
CY2021Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
9731810 usd
CY2022Q3 us-gaap Liabilities
Liabilities
31120092 usd
CY2021Q3 us-gaap Liabilities
Liabilities
29385212 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26413296 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26413296 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20782194 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20782194 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
26413 usd
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
20782 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
66616038 usd
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
61727834 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-54929020 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41908062 usd
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
148291 usd
CY2021Q3 us-gaap Treasury Stock Value
TreasuryStockValue
148291 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2377525 usd
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2896452 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
13944794 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
22590650 usd
CY2022Q3 us-gaap Minority Interest
MinorityInterest
692742 usd
CY2021Q3 us-gaap Minority Interest
MinorityInterest
964026 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
45757628 usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
52939888 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50274923 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
43130934 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
31219405 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
26162582 usd
CY2022 us-gaap Gross Profit
GrossProfit
19055518 usd
CY2021 us-gaap Gross Profit
GrossProfit
16968352 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27756159 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22538496 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4851720 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3171676 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
3316000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
35923879 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
25710172 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-16868361 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-8741820 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7265293 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8758212 usd
CY2021 CETX Settlement Agreement Related Party
SettlementAgreementRelatedParty
3674165 usd
CY2022 us-gaap Interest Expense
InterestExpense
3897719 usd
CY2021 us-gaap Interest Expense
InterestExpense
2921345 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3367574 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9511032 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13500787 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
769212 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-208545 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
375434 usd
CY2022 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-13292242 usd
CY2021 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
393778 usd
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-8280047 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-13292242 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-7886269 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-271284 usd
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-78274 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-13020958 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7807995 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-13292242 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-7886269 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-518927 usd
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
996100 usd
CY2021 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-87895 usd
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-13811169 usd
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-6802274 usd
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-271284 usd
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-78274 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13539885 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6724000 usd
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.52
CY2021 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.02
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.44
CY2022 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.52
CY2021 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.02
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.44
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24832056 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18911746 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24832056 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18911746 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
22590650 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-518927 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
155505 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3993124 usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
695400 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
50000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-13020958 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
13944794 usd
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
27806745 usd
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
27806745 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
996100 usd
CY2021 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
87895 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
156419 usd
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
5025651 usd
CY2021 CETX Stock Issued During Period Value Shares And Options Surrendered In Settlement Agreement
StockIssuedDuringPeriodValueSharesAndOptionsSurrenderedInSettlementAgreement
-3674165 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7807995 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
22590650 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
22590650 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-13292242 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-7886269 usd
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-8280047 usd
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-13292242 usd
CY2021 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
393778 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1862690 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1335189 usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-78707 usd
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-48981 usd
CY2022 us-gaap Noncash Contribution Expense
NoncashContributionExpense
616116 usd
CY2021 us-gaap Noncash Contribution Expense
NoncashContributionExpense
870860 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
3316000 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
73696 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-161856 usd
CY2022 CETX Provision For Doubtful Accounts Related Party
ProvisionForDoubtfulAccountsRelatedParty
708512 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
155505 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
156418 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-208545 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
375434 usd
CY2022 CETX Interest Expense Paid In Equity Shares
InterestExpensePaidInEquityShares
926646 usd
CY2021 CETX Interest Expense Paid In Equity Shares
InterestExpensePaidInEquityShares
1291596 usd
CY2022 CETX Accounts Payable Paid In Equity Shares
AccountsPayablePaidInEquityShares
50000 usd
CY2022 CETX Accrued Interest On Notes Payable
AccruedInterestOnNotesPayable
1043346 usd
CY2021 CETX Accrued Interest On Notes Payable
AccruedInterestOnNotesPayable
398321 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1544622 usd
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
675000 usd
CY2022 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
8399152 usd
CY2021 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
2612847 usd
CY2022 CETX Discharge Of Paycheck Protection Program Loans
DischargeOfPaycheckProtectionProgramLoans
971500 usd
CY2021 CETX Discharge Of Paycheck Protection Program Loans
DischargeOfPaycheckProtectionProgramLoans
5320485 usd
CY2021 CETX Settlement Agreement Related Party
SettlementAgreementRelatedParty
3674165 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1776514 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
962243 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
59960 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3874395 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
670838 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-48308 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1411653 usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
276740 usd
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-110534 usd
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-31273 usd
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
70576 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-978443 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-512138 usd
CY2022 CETX Increase Decrease In Accounts Payable Related Party
IncreaseDecreaseInAccountsPayableRelatedParty
36191 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-524188 usd
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-962790 usd
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-338042 usd
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
33310 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
660271 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
47389 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
86454 usd
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
506982 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-182562 usd
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-16558 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16093504 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10051165 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1844620 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1069283 usd
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
554335 usd
CY2022 CETX Payment To Acquire Other Investments
PaymentToAcquireOtherInvestments
500000 usd
CY2021 CETX Payment To Acquire Other Investments
PaymentToAcquireOtherInvestments
500000 usd
CY2021 CETX Payments For Investment In Virtual Driver Interactive
PaymentsForInvestmentInVirtualDriverInteractive
1075428 usd
CY2022 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
28302309 usd
CY2021 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
11477321 usd
CY2022 CETX Payment To Acquire Marketable Securities
PaymentToAcquireMarketableSecurities
19901897 usd
CY2021 CETX Payment To Acquire Marketable Securities
PaymentToAcquireMarketableSecurities
7991709 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
6610127 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
840901 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
8000000 usd
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
5005000 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1751763 usd
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2220257 usd
CY2021 CETX Payments On Capital Lease Liabilities
PaymentsOnCapitalLeaseLiabilities
20061 usd
CY2022 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
1225700 usd
CY2021 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
1261035 usd
CY2021 CETX Proceeds From Paycheck Protection Program Loans
ProceedsFromPaycheckProtectionProgramLoans
2942285 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5022537 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4445932 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
537387 usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-880834 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4460840 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4764332 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17186323 usd
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21069821 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12188096 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17186323 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10610181 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15426976 usd
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
1577915 usd
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
1759347 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
12188096 usd
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
17186323 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
383105 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
556428 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
353346 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-358876 usd
CY2021 CETX Investment In Virtual Driver Interactive
InvestmentInVirtualDriverInteractive
439774 usd
CY2022 CETX Stock Issued To Pay For Services
StockIssuedToPayForServices
50000 usd
CY2022 us-gaap Stock Issued1
StockIssued1
3993124 usd
CY2021 us-gaap Stock Issued1
StockIssued1
5025652 usd
CY2022 CETX Shares Issued In Connection With Note Payable
SharesIssuedInConnectionWithNotePayable
700400 usd
CY2022 CETX Investment In Right Of Use Asset
InvestmentInRightOfUseAsset
317187 usd
CY2022 us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_80B_eus-gaap--NatureOfOperations_zIdHQRrYBB3a" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_829_zwg6rlx0dMEd">ORGANIZATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cemtrex was incorporated in 1998, in the state of Delaware and has evolved through strategic acquisitions and internal growth into a leading multi-industry technology company. The Company has expanded in a wide range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security systems. Unless the context requires otherwise, all references to “we”, “our”, “us”, “Company”, “registrant”, “Cemtrex” or “management” refer to Cemtrex, Inc. and its subsidiaries.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Potential Impacts of COVID-19 on our Business</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The COVID-19 pandemic impacted our business operations and the results of our operations during fiscal years 2020 and 2021, primarily with delays in orders by many customers and new product development, including newer versions of surveillance software since our technical facility in Pune, India had been under lock down on multiple occasions. Bookings and revenue have recovered in this calendar year compared to last year. However, due to ongoing delays in certain supply chain areas, the expected launch times of our new products and new versions has resulted in delays of several months. These supply chain issues have also affected the Company’s ability to obtain inventory for our current bookings, and the Company has implemented a buildup of inventory levels to remain competitive and keep backlog orders at a minimum. Additionally, increased costs and the need to increase wages to retain talent may cause our gross margin percentages to shrink and our operational costs to rise. In response to these increased costs, the Company has implemented an ongoing review of our pricing to cover these additional costs while remaining competitive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The broader implications of COVID-19 on our results from operations going forward remains uncertain. The COVID-19 pandemic and the resulting supply chain issues and inflation has the potential to cause adverse effects to our customers, suppliers or business partners in locations that have or will experience more pronounced disruptions, which could result in a reduction to future revenue and manufacturing output as well as delays in our new product development activities. However, opportunities in the video surveillance field have been growing for Vicon products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The extent of the pandemics effect on our operational and financial performance will depend in large part on future developments, which cannot be reasonably estimated at this time. Future developments include the emergence of new virus variants that are more contagious or harmful than prior variants, the actions taken to contain or mitigate its impact both within and outside the jurisdictions where we operate, the impact on governmental programs and budgets, the development of treatments or vaccines, and the resumption of widespread economic activity. Due to the inherent uncertainty of the unprecedented and rapidly evolving situation, we are unable to predict with any confidence the likely impact of the COVID-19 pandemic on our future operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Going Concern Considerations</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with generally accepted accounting principles in the United States of America. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. Pursuant to the requirements of the ASC 205, management must evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for one year from the date these financial statements are issued.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This evaluation does not take into consideration the potential mitigating effect of management’s plans that have not been fully implemented or are not within control of the Company as of the date the financial statements are issued. When substantial doubt exists under this methodology, management evaluates whether the mitigating effect of its plans sufficiently alleviates substantial doubt about the Company’s ability to continue as a going concern. The mitigating effect of management’s plans, however, is only considered if both (1) it is probable that the plans will be effectively implemented within one year after the date that the financial statements are issued, and (2) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i/> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in; text-align: justify">The Company has incurred substantial losses of $<span id="xdx_90F_eus-gaap--NetIncomeLoss_iN_di_c20211001__20220930_zsze5ZjtDh9l" title="Net loss">13,020,958</span> and $<span id="xdx_904_eus-gaap--NetIncomeLoss_iN_di_c20201001__20210930_zUSUo0vzHXUd" title="Net loss">7,807,995</span> for fiscal years 2022 and 2021, respectively, and has debt obligations over the next fiscal year of $<span id="xdx_900_eus-gaap--LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_iI_c20220930_zX2QzCrWjxYc" title="Debt obligations">18,200,521</span> and working capital of $<span id="xdx_90A_ecustom--WorkingCapital_iI_c20220930_zi6zMxRpp958" title="Working capital">4,687,881</span>, that raise substantial doubt with respect to the Company’s ability to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in; text-align: justify">While our working capital and current debt indicate a substantial doubt regarding the Company’s ability to continue as a going concern, the Company has historically, from time to time, satisfied and may continue to satisfy certain short-term liabilities through the issuance of common stock, thus reducing our cash requirement to meet our operating needs. Additionally, the Company has recently sold unprofitable brands, reducing the cash required to maintain those brands, reevaluated our pricing model on our Vicon brand to improve margins on those products, and is working to effect a reverse stock split on our common stock to remain trading on the Nasdaq Capital Markets, and improve our ability to raise capital through equity offerings and reduce the number of shares the Company may use to satisfy debt. In the event additional capital is raised through equity offerings and/or debt is satisfied with equity, it may have a dilutive effect on our existing stockholders. While the Company believes these plans are sufficient to meet the capital demands of our current operations for at least the next twelve months, the is no guarantee that we will succeed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in; text-align: justify">Overall, there is no guarantee that cash flow from our existing or future operations and any external capital that we may be able to raise will be sufficient to meet our working capital needs. We currently do not have adequate cash to meet our short or long-term needs. The consolidated financial statements do not include any adjustments relating to this uncertainty.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Settlement with the Securities and Exchange Commission</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 30, 2022, acting pursuant to an offer of settlement submitted by the Company, the U.S. Securities and Exchange Commission (“SEC”) issued an order pursuant to Section 8A of the Securities Act, directing the Company to cease and desist from committing or causing any violations and any future violations of Section 17(a) of the Securities Act and Section 10(b) of the Exchange Act and Rule 10b-5 thereunder (the “SEC Order”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The SEC Order also directed Mr. Saagar Govil to cease and desist from committing or causing any violations and any future violations of Section 17(a)(3) of the Securities Act.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The SEC found that, as a result of its conduct, which was neither admitted nor denied, the Company violated Section 17(a) of the Securities Act and Section 10(b) of the Exchange Act and Rule 10b-5 thereunder, which prohibit fraudulent conduct in the offer or sale of securities and in connection with the purchase or sale of securities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The SEC also found that, as a result of his conduct, which was neither admitted nor denied, Mr. Govil violated Section 17(a)(3) of the Securities Act, which makes it illegal to engage in any transaction, practice, or course of business which operates or would operate as a fraud or deceit upon the purchaser.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to the above cease and desists, the Company undertook to not publicly announce that it has partnered with another company or that another company has become a customer of the Company without providing prior written notice, including a copy of the announcement text, to the businessperson at the other company responsible for that company’s relationship with the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also, the Company received a civil monetary penalty of two million two hundred thousand dollars ($<span id="xdx_902_ecustom--CivilMonetaryPenalty_c20211001__20220930_zNsNfTDaBSql" title="Civil monetary penalty">2,200,000</span>) in the aggregate that must be paid to the SEC. Mr. Govil also received a civil monetary penalty of three hundred and fifty thousand dollars ($<span id="xdx_903_ecustom--CivilMonetaryPenalty_c20211001__20220930__srt--TitleOfIndividualAxis__custom--MrGovilMember_zjj1NMPai6Kg" title="Civil monetary penalty">350,000</span>) in the aggregate that must be paid to the SEC. The company and Mr. Govil have remitted the payments as of September 30, 2022. The SEC Order can be accessed at www.sec.gov.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-13020958 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7807995 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
18200521 usd
CY2022Q3 CETX Working Capital
WorkingCapital
4687881 usd
CY2022 CETX Civil Monetary Penalty
CivilMonetaryPenalty
2200000 usd
CY2022 us-gaap Fiscal Period
FiscalPeriod
<p id="xdx_846_eus-gaap--FiscalPeriod_zreVICdiX8sg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fiscal Year-End</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company elected September 30 as its fiscal year-end date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50274923 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
43130934 usd
CY2022 us-gaap Gross Profit
GrossProfit
19055518 usd
CY2021 us-gaap Gross Profit
GrossProfit
16968352 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_zOkAZi38fw47" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Such estimates include, but are not limited to, provisions for doubtful trade receivables, net realizable value of inventory, warranty obligations, income tax accruals, deferred tax valuation and assessments of the recoverability of the Company’s long-lived assets. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-16868361 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-8741820 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3367574 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9511032 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
252688 usd
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
178992 usd
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
1088377 usd
CY2021 us-gaap Inventory Write Down
InventoryWriteDown
1921001 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
3316000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1862690 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1335189 usd
CY2022Q3 us-gaap Assets
Assets
45757628 usd
CY2021Q3 us-gaap Assets
Assets
52939888 usd
CY2021Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
1601932 usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2558591 usd
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2472137 usd
CY2022Q3 us-gaap Deposits
Deposits
198178 usd
CY2021Q3 us-gaap Deposits
Deposits
536220 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50274923 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
43130934 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13252773 usd
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
17500354 usd
CY2022Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
13721 usd
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1138702 usd
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18275798 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11160326 usd
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11536854 usd
CY2021Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
14981 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6738944 usd
CY2022Q3 CETX Lessee Operating Lease And Finance Lease Liability Payments Due Year Five
LesseeOperatingLeaseAndFinanceLeaseLiabilityPaymentsDueYearFive
187961 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2884875 usd
CY2022Q3 CETX Lessee Operating Lease And Finance Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseAndFinanceLeaseLiabilityUndiscountedExcessAmount
2884875 usd
CY2022Q3 CETX Operating Leases Amount Representing Interest
OperatingLeasesAmountRepresentingInterest
-243677 usd
CY2022Q3 CETX Leasea Operating Lease And Finance Lease Amount Representing Interest
LeaseaOperatingLeaseAndFinanceLeaseAmountRepresentingInterest
-243677 usd
CY2022 CETX Other Comprehensive Income Loss
OtherComprehensiveIncomeLoss
518927 usd
CY2021 CETX Other Comprehensive Income Loss
OtherComprehensiveIncomeLoss
996100 usd
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
1577915 usd
CY2022Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
6213374 usd
CY2021Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
7989888 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
252688 usd
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
178992 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5960686 usd
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7810896 usd
CY2022Q3 us-gaap Supplies
Supplies
414997 usd
CY2022Q3 CETX Costs And Estimated Earning In Excess Of Billings On Uncompleted Contracts Or Programs
CostsAndEstimatedEarningInExcessOfBillingsOnUncompletedContractsOrPrograms
781819 usd
CY2022Q3 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
37761 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1340528 usd
CY2021Q3 us-gaap Supplies
Supplies
298707 usd
CY2021Q3 CETX Costs And Estimated Earning In Excess Of Billings On Uncompleted Contracts Or Programs
CostsAndEstimatedEarningInExcessOfBillingsOnUncompletedContractsOrPrograms
1148243 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6106292 usd
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
2389232 usd
CY2021Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
1957410 usd
CY2022Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
145810 usd
CY2021Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
429871 usd
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8085017 usd
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5191007 usd
CY2022Q3 us-gaap Inventory Gross
InventoryGross
10620059 usd
CY2021Q3 us-gaap Inventory Gross
InventoryGross
7578288 usd
CY2022Q3 us-gaap Inventory Adjustments
InventoryAdjustments
1088377 usd
CY2021Q3 us-gaap Inventory Adjustments
InventoryAdjustments
1921001 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
9531682 usd
CY2021Q3 us-gaap Inventory Net
InventoryNet
5657287 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17266618 usd
CY2022Q3 us-gaap Other Assets
OtherAssets
1473980 usd
CY2022Q3 CETX Rent Security Deposits
RentSecurityDeposits
204388 usd
CY2022Q3 CETX Other Assets Excluding Rent And Investment
OtherAssetsExcludingRentAndInvestment
269592 usd
CY2021Q3 CETX Rent Security Deposits
RentSecurityDeposits
84362 usd
CY2021Q3 CETX Other Assets Excluding Rent And Investment
OtherAssetsExcludingRentAndInvestment
112878 usd
CY2020Q4 us-gaap Investments
Investments
500000 usd
CY2022Q1 us-gaap Investments
Investments
500000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
818730 usd
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
830791 usd
CY2022Q3 CETX Lease Liabilities Current
LeaseLiabilitiesCurrent
818730 usd
CY2021Q3 CETX Lease Liabilities Current
LeaseLiabilitiesCurrent
830791 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1822468 usd
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2017408 usd
CY2022Q3 CETX Longterm Lease Liabilities
LongtermLeaseLiabilities
1822468 usd
CY2021Q3 CETX Longterm Lease Liabilities
LongtermLeaseLiabilities
2017408 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
853544 usd
CY2022Q3 CETX Lessee Operating Lease And Finance Lease Liability Payments Next Twelve Months
LesseeOperatingLeaseAndFinanceLeaseLiabilityPaymentsNextTwelveMonths
853544 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
672828 usd
CY2022Q3 CETX Lessee Operating Lease And Finance Lease Liability Payments Due Year Two
LesseeOperatingLeaseAndFinanceLeaseLiabilityPaymentsDueYearTwo
672828 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
650494 usd
CY2022Q3 CETX Lessee Operating Lease And Finance Lease Liability Payments Due Year Three
LesseeOperatingLeaseAndFinanceLeaseLiabilityPaymentsDueYearThree
650494 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
520048 usd
CY2022Q3 CETX Lessee Operating Lease And Finance Lease Liability Payments Due Year Four
LesseeOperatingLeaseAndFinanceLeaseLiabilityPaymentsDueYearFour
520048 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
187961 usd
CY2022Q3 CETX Lessee Operating Lease Liability Discounted Excess Amount
LesseeOperatingLeaseLiabilityDiscountedExcessAmount
2641198 usd
CY2022Q3 CETX Lessee Operating Lease And Finance Lease Liability Discounted Excess Amount
LesseeOperatingLeaseAndFinanceLeaseLiabilityDiscountedExcessAmount
2641198 usd
CY2021 CETX Depreciation Of Finance Lease Assets
DepreciationOfFinanceLeaseAssets
17184 usd
CY2021 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
88 usd
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
686124 usd
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
980062 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
978443 usd
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
962790 usd
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
20061 usd
CY2022 CETX Operating And Finance Lease Payments
OperatingAndFinanceLeasePayments
978443 usd
CY2021 CETX Operating And Finance Lease Payments
OperatingAndFinanceLeasePayments
982851 usd
CY2022Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0M
CY2021Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0M
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P33M
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P55M
CY2021Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0363 pure
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0566 pure
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0685 pure
CY2022Q3 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2021Q3 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
18200521 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
186005 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
156361 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
123010 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
127986 usd
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
1774258 usd
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
20568141 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2129122 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1935151 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2065022 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1871051 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26413296 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26413296 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20782194 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20782194 shares
CY2022 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5481102 shares
CY2022Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
4688524 usd
CY2021Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
5025651 usd
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0292 pure
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.1056 pure
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
155505 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
156419 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
221380 usd
CY2022 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y3M
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
950000 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.74
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y6M
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
410260 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.39
CY2022 CETX Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P0Y6M25D
CY2022 CETX Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod
-150000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.34
CY2022 CETX Sharebased Compensation Arrangement By Sharebased Payment Award Options Cancelled Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsCancelledWeightedAverageRemainingContractualTerm
P4Y
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1210260 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.34
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y3M
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
650000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.80
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y3M
CY2022Q3 us-gaap Area Of Land
AreaOfLand
2500 sqft
CY2022 us-gaap Payments For Rent
PaymentsForRent
10000 usd
CY2022 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
The Tax Cuts and Jobs Act (the “Tax Act”) was enacted on December 22, 2017. The Tax Act reduces the maximum U.S. federal corporate tax rate from 35% to 21%
CY2022 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
The net operating loss carryforwards, if not utilized, will begin to expire in 2036 for federal purposes and in 2036 for state purposes
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-12103393 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
30957 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-1397394 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
738255 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13500787 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
769212 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-208545 usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
375434 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-208545 usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
375434 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-208545 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
375434 usd
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0154 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.4881 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0122 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0650 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.0104 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.0000 pure
CY2022 CETX Effective Income Tax Rate Reconciliation Change In Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInValuationAllowance
0.1373 pure
CY2021 CETX Effective Income Tax Rate Reconciliation Change In Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInValuationAllowance
-0.0000 pure
CY2022 CETX Effective Income Tax Rate Reconciliation Return To Provision
EffectiveIncomeTaxRateReconciliationReturnToProvision
-0.0133 pure
CY2021 CETX Effective Income Tax Rate Reconciliation Return To Provision
EffectiveIncomeTaxRateReconciliationReturnToProvision
-0.0000 pure
CY2022 CETX Effective Income Tax Rate Reconciliation Goodwill Impairment
EffectiveIncomeTaxRateReconciliationGoodwillImpairment
-0.0516 pure
CY2021 CETX Effective Income Tax Rate Reconciliation Goodwill Impairment
EffectiveIncomeTaxRateReconciliationGoodwillImpairment
0.0000 pure
CY2022 CETX Effective Income Tax Rate Reconciliation Settlement Payment
EffectiveIncomeTaxRateReconciliationSettlementPayment
-0.0342 pure
CY2021 CETX Effective Income Tax Rate Reconciliation Settlement Payment
EffectiveIncomeTaxRateReconciliationSettlementPayment
0.0000 pure
CY2022 CETX Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Paycheck Protection Program Loan Forgiveness
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRatePaycheckProtectionProgramLoanForgiveness
0.0151 pure
CY2021 CETX Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Paycheck Protection Program Loan Forgiveness
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRatePaycheckProtectionProgramLoanForgiveness
0.0000 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.0017 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.2131 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0154 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.4881 pure
CY2022Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
18563887 usd
CY2021Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
8702738 usd
CY2022Q3 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1330547 usd
CY2021Q3 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1405057 usd
CY2022Q3 CETX Deferred Tax Assets Allowance For Bad Debt
DeferredTaxAssetsAllowanceForBadDebt
8304 usd
CY2021Q3 CETX Deferred Tax Assets Allowance For Bad Debt
DeferredTaxAssetsAllowanceForBadDebt
35345 usd
CY2022Q3 CETX Deferred Tax Assets Warrants Interest Expense
DeferredTaxAssetsWarrantsInterestExpense
2975593 usd
CY2021Q3 CETX Deferred Tax Assets Warrants Interest Expense
DeferredTaxAssetsWarrantsInterestExpense
1155642 usd
CY2022Q3 CETX Deferred Tax Assets Accruals
DeferredTaxAssetsAccruals
289426 usd
CY2021Q3 CETX Deferred Tax Assets Accruals
DeferredTaxAssetsAccruals
280447 usd
CY2022Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
27764 usd
CY2021Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
28002 usd
CY2022Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
5847 usd
CY2021Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
4358 usd
CY2022Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
23201368 usd
CY2021Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
11611589 usd
CY2022Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
20895094 usd
CY2021Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9491650 usd
CY2022Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2306274 usd
CY2021Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2119939 usd
CY2022Q3 CETX Deferred Tax Liabilities Inventory And Other Reserves
DeferredTaxLiabilitiesInventoryAndOtherReserves
490967 usd
CY2021Q3 CETX Deferred Tax Liabilities Inventory And Other Reserves
DeferredTaxLiabilitiesInventoryAndOtherReserves
638230 usd
CY2022Q3 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
124399 usd
CY2021Q3 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
87934 usd
CY2022Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
525898 usd
CY2021Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
557074 usd
CY2022Q3 CETX Deferred Tax Liabilities Goodwill And Depreciation
DeferredTaxLiabilitiesGoodwillAndDepreciation
1165010 usd
CY2021Q3 CETX Deferred Tax Liabilities Goodwill And Depreciation
DeferredTaxLiabilitiesGoodwillAndDepreciation
836701 usd
CY2022Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
2306274 usd
CY2021Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
2119939 usd

Files In Submission

Name View Source Status
0001493152-22-036671-index-headers.html Edgar Link pending
0001493152-22-036671-index.html Edgar Link pending
0001493152-22-036671.txt Edgar Link pending
0001493152-22-036671-xbrl.zip Edgar Link pending
cetx-20220930.xsd Edgar Link pending
ex21-1.htm Edgar Link pending
ex23-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
cetx-20220930_cal.xml Edgar Link unprocessable
cetx-20220930_def.xml Edgar Link unprocessable
cetx-20220930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cetx-20220930_lab.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending